Usa Financial Portformulas Corp Haemonetics Corp Transaction History

Usa Financial Portformulas Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Nov 27, 2023	SELL	$80.84 - $89.45 $889 - $983	-11 Reduced 3.38%	314 $26,000
Q1 2023 Nov 27, 2023	SELL	$72.75 - $90.6 $65,984 - $82,174	-907 Reduced 73.62%	325 $26,000
Q3 2022 Oct 24, 2022	BUY	$63.3 - $78.66 $77,985 - $96,909	1,232 New	1,232 $91,000
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $290,655 - $373,915	-3,206 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$89.96 - $114.58 $288,411 - $367,343	3,206 New	3,206 $288,000

333

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.